COGSCREEN, LLC
ST. PETERSBURG, FLORIDA

Founded in August 2010 by Dr. Gary Kay, COGSCREEN, LLC has become a well-recognized player known for its innovative cognitive screening tools, CogScreen- and CogScreen-AE. Based out of St. Petersburg, Florida, the company prides itself on a strong foundation built upon years of neurological research and pioneering developments. Dr. Kay's impressive resume includes his past role as Director of the Neuropsychology Division at Georgetown University’s Department of Neurology, which has significantly influenced the company's approach to crafting computerized cognitive assessments. These tools are expertly designed to spot even subtle changes in areas like attention, memory, visual perception, problem-solving skills, and executive functions-an attribute that has made them indispensable to federal agencies such as the FAA. The primary product, CogScreen-, emerged from a need identified by the FAA for an assessment tool capable of detecting minor but critical cognitive shifts affecting aviation safety. Its extension, CogScreen-AE, meets specific FAA requirements by evaluating perceptual and processing skills crucial to pilots without focusing on actual flying abilities. COGSCREEN's dedication to accuracy extends to analyzing medication impacts on cognition, stemming from Dr. Kay’s research into the neuro-psychological effects of various substances including sedating antihistamines and hormone replacement therapies. Operating as an FLAL company since its incorporation in Florida, COGSCREEN, LLC has a solid corporate structure maintained through consistent compliance-as evidenced by its latest annual report filed on February 18, 2024. Dr. Gary Kay continues to spearhead the organization’s ongoing research and development efforts. Beyond aviation, COGSCREEN is making waves across various medical domains by enhancing healthcare diagnostics with advanced cognitive evaluation technology. For more information, you can visit their website at cogscreen.com.